Transforming Traditional Industry Advisory Boards Into Mutually Beneficial Strategic Think Tanks: A Peer Review Council Case Series and Best Practices

IF 2.7 4区 医学 Q2 PHARMACOLOGY & PHARMACY
Todd Williamson, John Fox, Scott Ramsey, Maria Martins-Lopes, Kevin M. Pantalone, C. Daniel Mullins, Kenneth Schaecher, Sean D. Sullivan
{"title":"Transforming Traditional Industry Advisory Boards Into Mutually Beneficial Strategic Think Tanks: A Peer Review Council Case Series and Best Practices","authors":"Todd Williamson,&nbsp;John Fox,&nbsp;Scott Ramsey,&nbsp;Maria Martins-Lopes,&nbsp;Kevin M. Pantalone,&nbsp;C. Daniel Mullins,&nbsp;Kenneth Schaecher,&nbsp;Sean D. Sullivan","doi":"10.1007/s12247-025-09925-2","DOIUrl":null,"url":null,"abstract":"<p>The Bayer Data Generation and Observational Studies (DGOS) team has partnered longitudinally with a consistent advisor group (DGOS Council). The DGOS Council operates as an extension of the DGOS team, providing external strategic perspectives. Here, we describe Bayer’s engagement with the DGOS Council and how it contributes throughout a product’s lifecycle. We present the composition and organization of the DGOS Council, share case studies describing its relation to and impact across Bayer’s portfolio of products, and discuss bi-directional benefits to Bayer and DGOS Council members. We conclude with recommendations for best practices for an HEOR Peer Review Council model. Teaser. Bayer has partnered longitudinally with a group of strategic advisors. The relationship between Bayer and the advisors is described here as a consideration for best practice for evidence generation teams. </p>","PeriodicalId":656,"journal":{"name":"Journal of Pharmaceutical Innovation","volume":"20 1","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2025-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s12247-025-09925-2.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmaceutical Innovation","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s12247-025-09925-2","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

The Bayer Data Generation and Observational Studies (DGOS) team has partnered longitudinally with a consistent advisor group (DGOS Council). The DGOS Council operates as an extension of the DGOS team, providing external strategic perspectives. Here, we describe Bayer’s engagement with the DGOS Council and how it contributes throughout a product’s lifecycle. We present the composition and organization of the DGOS Council, share case studies describing its relation to and impact across Bayer’s portfolio of products, and discuss bi-directional benefits to Bayer and DGOS Council members. We conclude with recommendations for best practices for an HEOR Peer Review Council model. Teaser. Bayer has partnered longitudinally with a group of strategic advisors. The relationship between Bayer and the advisors is described here as a consideration for best practice for evidence generation teams. 

将传统行业咨询委员会转变为互利的战略智库:同行评审委员会案例系列和最佳实践
拜耳数据生成和观察研究(DGOS)团队与一致的顾问小组(DGOS理事会)进行了纵向合作。DGOS理事会作为DGOS团队的延伸运作,提供外部战略观点。在这里,我们描述了拜耳与DGOS委员会的合作,以及它如何在产品的整个生命周期中做出贡献。我们介绍了DGOS委员会的组成和组织,分享了案例研究,描述了它与拜耳产品组合的关系和影响,并讨论了拜耳和DGOS委员会成员的双向利益。最后,我们对高等学校同行评审委员会模式的最佳做法提出了建议。急转弯。拜耳与一组战略顾问进行了长期合作。拜耳和顾问之间的关系在这里被描述为对证据生成团队最佳实践的考虑。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Pharmaceutical Innovation
Journal of Pharmaceutical Innovation PHARMACOLOGY & PHARMACY-
CiteScore
3.70
自引率
3.80%
发文量
90
审稿时长
>12 weeks
期刊介绍: The Journal of Pharmaceutical Innovation (JPI), is an international, multidisciplinary peer-reviewed scientific journal dedicated to publishing high quality papers emphasizing innovative research and applied technologies within the pharmaceutical and biotechnology industries. JPI''s goal is to be the premier communication vehicle for the critical body of knowledge that is needed for scientific evolution and technical innovation, from R&D to market. Topics will fall under the following categories: Materials science, Product design, Process design, optimization, automation and control, Facilities; Information management, Regulatory policy and strategy, Supply chain developments , Education and professional development, Journal of Pharmaceutical Innovation publishes four issues a year.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信